Research pathwayMetabolic research
Retatrutide
CA$80.00& up
Retatrutide
Lyophilized peptide for research use only.
From CA$80.00
10 mg · 5 mg · 20 mg
Six pathways
Compounds grouped by the biology under study.
- 01
Metabolic research
Retatrutide and tirzepatide are studied in incretin-receptor pharmacology; 5-Amino-1MQ is studied as an enzyme target in nicotinamide and adipocyte metabolism.
Open pathway - 02
Repair pathways
BPC-157, GHK-Cu, and thymosin β4 studies describe angiogenesis, fibroblast and extracellular-matrix biology, actin dynamics, and cell migration. Published rodent injury and cell-culture studies provide the predominant evidence.
Open pathway - 03
Cellular energy
MOTS-c, NAD+, and 5-Amino-1MQ are studied in mitochondrial signalling, NAD-dependent redox chemistry, AMPK activation, and substrate utilisation under metabolic stress.
Open pathway - 04
Cellular ageing
NAD+ and GHK-Cu studies describe sirtuin and PARP substrate availability and extracellular-matrix remodelling in ageing models.
Open pathway - 05
Neural signalling
Melanotan II and Ipamorelin studies describe melanocortin and ghrelin-receptor signalling in the CNS and hypothalamic appetite and stress pathways.
Open pathway - 06
Performance biology
Ipamorelin, Tesamorelin, and IGF-1 LR3 studies describe GH-secretagogue and GHRH-receptor pharmacology, IGF-1 receptor signalling, and skeletal-muscle models.
Open pathway
The Jastreboff et al. trial reported a −24.2% least-squares mean body-weight change at week 48 in 338 adults with obesity, or overweight plus a weight-related condition, without diabetes. Jastreboff et al., NEJM 2023 ↗
The Jastreboff et al. SURMOUNT-1 trial reported a −20.9% mean body-weight change at week 72 in 2,539 adults with obesity, or overweight plus a complication, excluding diabetes. Jastreboff et al., NEJM 2022 ↗
Every finding, traced to its paper.
Study or model · population · finding · evidence tier · source · limitation